Back to Top

PRESS RELEASES

SOURCE: Press and Public Affairs Bureau


MARCOLETA: HOUSE INQUIRY ON COVID-19 PROCUREMENT A SEARCH FOR TRUTH, NOT A FIGHT WITH SENATE
22 September 2021 03:10:21 PM


The ongoing House inquiry on the procurement of COVID-19 medical supplies is a search for truth and does not intend to pit the House of Representatives against the Senate.

This was underscored by Deputy Speaker and SAGIP Party-list Rep. Rodante Marcoleta during the virtual Ugnayan sa Batasan media forum held on Wednesday.

The House leader also noted the difference in the approach of the two chambers of Congress in undertaking the probe into the billions of pesos worth of medical supplies bought by the Department of Health (DOH)—through the Procurement Service of the Department of Budget and Management (PS-DBM)—from Pharmally Pharmaceutical Corp.

“Napansin nyo naman siguro ang pagkakaiba sa uri at tsaka pagtatanong na ginagawa ng dalawang kapulungan ng Kongreso,” Marcoleta said, referring to the manner of questioning and treatment by senators and House members on the resource persons invited to their respective inquiries.

“Sa amin naman ang kaibahan ‘yong pagbibigay namin sa kanila ng kaukulang panahon para maipaliwanag nila ‘yong inaakala ng marami na ma-anomalyang pangyayari una sa pagkaka-transfer ng pondo ng DOH sa PS-DBM,” he added.

The Committee on Good Government and Public Accountability is leading the House inquiry into the alleged overpricing of medical supplies procured by the government for COVID-19 response.

During the House hearing, no less than Commission on Audit Chairman Michael Aguinaldo said there was no findings of overpricing in the Pharmally deal, leading some House members to conclude that there was no corruption in the procurement.

It was also learned that although the procurement was exempted from the coverage of Republic Act 9184 or the Government Procurement Reform Act, budget officials “went over and above the requirements of the law” by conducting market scanning to ensure the most advantageous price for the government.

Marcoleta, meanwhile, denied allegations that the House inquiry actually aims to defend President Rodrigo Roa Duterte and his Cabinet officials who are being dragged into the controversy.

“Ang aming ginagawa ay pantulong lamang para malaman natin talaga kung ano ang totoo, maserbisyuhan natin ang ating taumbayan na makaunawa talaga sapagkat sila man ay interesado sapagkat pera ng bayan ang pinag-uusapan,” Marcoleta said.

He added: “Kailangan malinaw natin mabuti ito kung mayroong pagtatakip, mayroong anomalya, kung mayroong corruption kailangan malaman nila. So sa pamamagitan ng ginagawa naming pagdinig makatutulong kami sa paghanap ng solusyon na yun kung talagang meron nga.”

Marcoleta revealed that the Committee on Good Government and Public Accountability might conclude its inquiry by Friday, noting that the crucial questions have already been asked in the previous hearings.

“Noong una gusto naming mapagpasyahan kung may determination ng corruption, ng overpricing at tsaka ng ghost delivery. Ito’y isa-isang naipaliliwanag at sa tingin namin tama ang sinabi ng COA na hindi naman corruption ang pinag-uusapan namin nung i-flag namin ‘yan kundi deficiency lamang dun sa dokumento na nire-require namin sa pagkaka-transfer ng pera,” Marcoleta explained.

Marcoleta also said that should there be anomalies uncovered during the investigation, these should be referred instead to the National Prosecution Service or the National Bureau of Investigation (NBI), which are both under the Department of Justice (DOJ).

“Sila naman ang may kakayahan na ipagpatuloy ang ganitong klaseng pag-uusig kung mayroong anomalya,” Marcoleta said. “Hindi prosecutorial office ang alinmang kapulungan ng Kongreso.”